title: Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
abstract: OBJECTIVE
  Data on oxidative stress in type 2 diabetic patients with diabetic nephropathy is scant. The objective of this study was to investigate possible associations between total oxidant status (TOS) and the severity of diabetic nephropathy in type 2 diabetic patients by using a novel automated measurement method.
  
  
  RESULTS
  Thirty-six patients with diabetic nephropathy (group 1), 25 diabetic patients without nephropathy (group 2) and 30 controls (group 3) were enrolled. Serum total antioxidant capacity (TAC), TOS levels and oxidative stress index (OSI) were determined. The severity of the disease was determined with microalbuminuria levels. TAC was lower, while TOS and OSI were higher in group 1 than in group 3 (P<0.01, P<0.001, P<0.001; respectively). There were no statistically significant differences between group 2 and group 3 with respect to TAC, TOS and OSI (all P>0.05). Group 1 had higher TOS and OSI than group 2 (both P<0.05), but there was no statistically significant difference with respect to TAC. Significant correlations were observed between microalbuminuria levels, and TAC, TOS and OSI levels (r=-0.616, P<0.001; r=0.488, P<0.01; r=0.567, P<0.001; respectively).
  
  
  CONCLUSIONS
  Our results suggest that oxidative stress is increased in patients with diabetic nephropathy compared to diabetic patients without nephropathy and this increase seems to be related to the severity of microalbuminuria levels.
authors.affiliation: Department of Endocrinology, Faculty of Medicine, Harran University, Sanliurfa, Turkey. m.aslan301@mynet.com
authors.forename: Mehmet
authors.initials: M
authors.lastname: Aslan
authors.forename: Tevfik
authors.initials: T
authors.lastname: Sabuncu
authors.forename: Abdurrahim
authors.initials: A
authors.lastname: Kocyigit
authors.forename: Hakim
authors.initials: H
authors.lastname: Celik
authors.forename: Sahbettin
authors.initials: S
authors.lastname: Selek
mesh_terms: D000328:Adult; D000419:Albuminuria / Q000378:metabolism* / Q000473:pathology; D000975:Antioxidants / Q000378:metabolism*; D015415:Biomarkers; D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism* / Q000473:pathology; D003928:Diabetic Nephropathies / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D012720:Severity of Illness Index
chemical_list: D000975:Antioxidants; D015415:Biomarkers